Carbon	B:C0007018
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	B:C0184511
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	B:C3178844
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	B:C0243026
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	B:C0243095
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	B:C3658313
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	B:C0030660
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	B:C2825142
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	B:C0599779
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	O
.	O

Carbon	O
Monoxide	I:C0007018
Improves	O
Efficacy	O
of	O
Mesenchymal	O
Stromal	I:C3178844
Cells	I:C3178844
During	O
Sepsis	O
by	O
Production	O
of	O
Specialized	O
Proresolving	O
Lipid	O
Mediators	O
Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
are	O
being	O
investigated	O
as	O
a	O
cell	O
-	I:C3658313
based	I:C3658313
therapy	I:C3658313
for	O
a	O
number	O
of	O
disease	O
processes	I:C0030660
,	O
with	O
promising	O
results	O
in	O
animal	O
models	I:C0599779
of	O
systemic	O
inflammation	O
and	O
sepsis	B:C0243026
.	O

Studies	B:C2603343
are	O
ongoing	O
to	O
determine	O
ways	O
to	O
further	O
improve	O
the	O
therapeutic	O
potential	O
of	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
.	O

Studies	O
are	O
ongoing	O
to	O
determine	O
ways	O
to	O
further	O
improve	B:C0184511
the	O
therapeutic	O
potential	O
of	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
.	O

Studies	O
are	O
ongoing	O
to	O
determine	O
ways	O
to	O
further	O
improve	O
the	O
therapeutic	O
potential	O
of	O
mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
.	O

A	O
gas	B:C0017110
molecule	O
that	O
improves	O
outcome	O
in	O
experimental	O
sepsis	O
is	O
carbon	O
monoxide	I:C0007018
.	O

A	O
gas	O
molecule	O
that	O
improves	B:C0184511
outcome	O
in	O
experimental	O
sepsis	O
is	O
carbon	O
monoxide	I:C0007018
.	O

A	O
gas	O
molecule	O
that	O
improves	O
outcome	O
in	O
experimental	O
sepsis	B:C0243026
is	O
carbon	O
monoxide	I:C0007018
.	O

A	O
gas	O
molecule	O
that	O
improves	O
outcome	O
in	O
experimental	O
sepsis	O
is	O
carbon	B:C0007018
monoxide	I:C0007018
.	O

We	O
hypothesized	O
that	O
preconditioning	O
of	O
mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
with	O
carbon	O
monoxide	I:C0007018
ex	O
vivo	O
would	O
promote	O
further	O
therapeutic	O
benefit	O
when	O
cells	O
are	O
administered	O
in	O
vivo	I:C1515655
after	O
the	O
onset	O
of	O
polymicrobial	O
sepsis	O
in	O
mice	O
.	O

We	O
hypothesized	O
that	O
preconditioning	O
of	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
with	O
carbon	B:C0007018
monoxide	I:C0007018
ex	O
vivo	O
would	O
promote	O
further	O
therapeutic	O
benefit	O
when	O
cells	O
are	O
administered	O
in	O
vivo	I:C1515655
after	O
the	O
onset	O
of	O
polymicrobial	O
sepsis	O
in	O
mice	O
.	O

We	O
hypothesized	O
that	O
preconditioning	O
of	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
with	O
carbon	O
monoxide	I:C0007018
ex	O
vivo	O
would	O
promote	O
further	O
therapeutic	O
benefit	O
when	O
cells	B:C0007634
are	O
administered	O
in	O
vivo	I:C1515655
after	O
the	O
onset	O
of	O
polymicrobial	O
sepsis	O
in	O
mice	O
.	O

We	O
hypothesized	O
that	O
preconditioning	O
of	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
with	O
carbon	O
monoxide	I:C0007018
ex	O
vivo	O
would	O
promote	O
further	O
therapeutic	O
benefit	O
when	O
cells	O
are	O
administered	O
in	B:C1515655
vivo	I:C1515655
after	O
the	O
onset	O
of	O
polymicrobial	O
sepsis	O
in	O
mice	O
.	O

We	O
hypothesized	O
that	O
preconditioning	O
of	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
with	O
carbon	O
monoxide	I:C0007018
ex	O
vivo	O
would	O
promote	O
further	O
therapeutic	O
benefit	O
when	O
cells	O
are	O
administered	O
in	O
vivo	I:C1515655
after	O
the	O
onset	O
of	O
polymicrobial	B:C0275524
sepsis	O
in	O
mice	O
.	O

We	O
hypothesized	O
that	O
preconditioning	O
of	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
with	O
carbon	O
monoxide	I:C0007018
ex	O
vivo	O
would	O
promote	O
further	O
therapeutic	O
benefit	O
when	O
cells	O
are	O
administered	O
in	O
vivo	I:C1515655
after	O
the	O
onset	O
of	O
polymicrobial	O
sepsis	B:C0243026
in	O
mice	O
.	O

We	O
hypothesized	O
that	O
preconditioning	O
of	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
with	O
carbon	O
monoxide	I:C0007018
ex	O
vivo	O
would	O
promote	O
further	O
therapeutic	O
benefit	O
when	O
cells	O
are	O
administered	O
in	O
vivo	I:C1515655
after	O
the	O
onset	O
of	O
polymicrobial	O
sepsis	O
in	O
mice	B:C0025929
.	O

Animal	B:C0683949
study	I:C0683949
and	O
primary	O
cell	I:C1449562
culture	I:C1449562
.	O

Animal	O
study	I:C0683949
and	O
primary	B:C1449562
cell	I:C1449562
culture	I:C1449562
.	O

Laboratory	B:C0022877
investigation	O
.	O

Laboratory	O
investigation	B:C0220825
.	O

BALB	B:C0025919
/	I:C0025919
c	I:C0025919
mice	I:C0025919
.	O

Polymicrobial	B:C0275524
sepsis	O
was	O
induced	O
by	O
cecal	O
ligation	O
and	O
puncture	O
.	O

Polymicrobial	O
sepsis	B:C0243026
was	O
induced	O
by	O
cecal	O
ligation	O
and	O
puncture	O
.	O

Polymicrobial	O
sepsis	O
was	O
induced	O
by	O
cecal	B:C0007531
ligation	O
and	O
puncture	O
.	O

Polymicrobial	O
sepsis	O
was	O
induced	O
by	O
cecal	O
ligation	B:C0023690
and	O
puncture	O
.	O

Polymicrobial	O
sepsis	O
was	O
induced	O
by	O
cecal	O
ligation	O
and	O
puncture	B:C0034117
.	O

Mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
,	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
,	O
fibroblasts	O
,	O
or	O
fibroblasts	O
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
were	O
delivered	O
by	O
tail	O
vein	I:C2985205
injections	O
to	O
septic	O
mice	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
,	O
mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
,	O
fibroblasts	O
,	O
or	O
fibroblasts	O
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
were	O
delivered	O
by	O
tail	O
vein	I:C2985205
injections	O
to	O
septic	O
mice	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
,	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
-	O
conditioned	O
with	O
carbon	B:C0007018
monoxide	I:C0007018
,	O
fibroblasts	O
,	O
or	O
fibroblasts	O
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
were	O
delivered	O
by	O
tail	O
vein	I:C2985205
injections	O
to	O
septic	O
mice	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
,	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
,	O
fibroblasts	B:C0016030
,	O
or	O
fibroblasts	O
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
were	O
delivered	O
by	O
tail	O
vein	I:C2985205
injections	O
to	O
septic	O
mice	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
,	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
,	O
fibroblasts	O
,	O
or	O
fibroblasts	B:C0016030
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
were	O
delivered	O
by	O
tail	O
vein	I:C2985205
injections	O
to	O
septic	O
mice	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
,	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
,	O
fibroblasts	O
,	O
or	O
fibroblasts	O
-	O
conditioned	O
with	O
carbon	B:C0007018
monoxide	I:C0007018
were	O
delivered	O
by	O
tail	O
vein	I:C2985205
injections	O
to	O
septic	O
mice	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
,	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
,	O
fibroblasts	O
,	O
or	O
fibroblasts	O
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
were	O
delivered	O
by	O
tail	B:C2985205
vein	I:C2985205
injections	O
to	O
septic	O
mice	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
,	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
,	O
fibroblasts	O
,	O
or	O
fibroblasts	O
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
were	O
delivered	O
by	O
tail	O
vein	I:C2985205
injections	B:C1533685
to	O
septic	O
mice	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
,	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
,	O
fibroblasts	O
,	O
or	O
fibroblasts	O
-	O
conditioned	O
with	O
carbon	O
monoxide	I:C0007018
were	O
delivered	O
by	O
tail	O
vein	I:C2985205
injections	O
to	O
septic	O
mice	B:C0025929
.	O

The	O
mice	B:C0025929
were	O
assessed	O
for	O
survival	O
,	O
bacterial	O
clearance	O
,	O
and	O
the	O
inflammatory	O
response	I:C1155266
during	O
sepsis	O
in	O
each	O
of	O
the	O
groups	O
.	O

The	O
mice	O
were	O
assessed	O
for	O
survival	O
,	O
bacterial	O
clearance	O
,	O
and	O
the	O
inflammatory	B:C1155266
response	I:C1155266
during	O
sepsis	O
in	O
each	O
of	O
the	O
groups	O
.	O

The	O
mice	O
were	O
assessed	O
for	O
survival	O
,	O
bacterial	O
clearance	O
,	O
and	O
the	O
inflammatory	O
response	I:C1155266
during	O
sepsis	B:C0243026
in	O
each	O
of	O
the	O
groups	O
.	O

Mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
assessed	O
for	O
their	O
ability	O
to	O
promote	O
bacterial	O
phagocytosis	O
by	O
neutrophils	O
,	O
the	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
and	O
their	O
importance	O
for	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
function	O
using	O
gene	O
silencing	I:C0598496
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
assessed	O
for	O
their	O
ability	O
to	O
promote	O
bacterial	O
phagocytosis	B:C0031308
by	O
neutrophils	O
,	O
the	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
and	O
their	O
importance	O
for	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
function	O
using	O
gene	O
silencing	I:C0598496
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
assessed	O
for	O
their	O
ability	O
to	O
promote	O
bacterial	O
phagocytosis	O
by	O
neutrophils	B:C0027950
,	O
the	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
and	O
their	O
importance	O
for	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
function	O
using	O
gene	O
silencing	I:C0598496
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
assessed	O
for	O
their	O
ability	O
to	O
promote	O
bacterial	O
phagocytosis	O
by	O
neutrophils	O
,	O
the	O
production	O
of	O
specialized	O
proresolving	B:C0243095
lipid	O
mediators	O
,	O
and	O
their	O
importance	O
for	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
function	O
using	O
gene	O
silencing	I:C0598496
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
assessed	O
for	O
their	O
ability	O
to	O
promote	O
bacterial	O
phagocytosis	O
by	O
neutrophils	O
,	O
the	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
and	O
their	O
importance	O
for	O
mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
function	O
using	O
gene	O
silencing	I:C0598496
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
assessed	O
for	O
their	O
ability	O
to	O
promote	O
bacterial	O
phagocytosis	O
by	O
neutrophils	O
,	O
the	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
and	O
their	O
importance	O
for	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
function	B:C0031843
using	O
gene	O
silencing	I:C0598496
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
assessed	O
for	O
their	O
ability	O
to	O
promote	O
bacterial	O
phagocytosis	O
by	O
neutrophils	O
,	O
the	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
and	O
their	O
importance	O
for	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
function	O
using	O
gene	B:C0598496
silencing	I:C0598496
.	O

Ex	O
vivo	O
preconditioning	O
with	O
carbon	B:C0007018
monoxide	I:C0007018
allowed	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
to	O
be	O
administered	O
later	O
after	O
the	O
onset	O
of	O
sepsis	O
(	O
6	O
hr	O
)	O
,	O
and	O
yet	O
maintain	O
their	O
therapeutic	O
effect	I:C1527144
with	O
increased	O
survival	O
.	O

Ex	O
vivo	O
preconditioning	O
with	O
carbon	O
monoxide	I:C0007018
allowed	O
mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
to	O
be	O
administered	O
later	O
after	O
the	O
onset	O
of	O
sepsis	O
(	O
6	O
hr	O
)	O
,	O
and	O
yet	O
maintain	O
their	O
therapeutic	O
effect	I:C1527144
with	O
increased	O
survival	O
.	O

Ex	O
vivo	O
preconditioning	O
with	O
carbon	O
monoxide	I:C0007018
allowed	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
to	O
be	O
administered	O
later	O
after	O
the	O
onset	O
of	O
sepsis	B:C0243026
(	O
6	O
hr	O
)	O
,	O
and	O
yet	O
maintain	O
their	O
therapeutic	O
effect	I:C1527144
with	O
increased	O
survival	O
.	O

Ex	O
vivo	O
preconditioning	O
with	O
carbon	O
monoxide	I:C0007018
allowed	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
to	O
be	O
administered	O
later	O
after	O
the	O
onset	O
of	O
sepsis	O
(	O
6	O
hr	O
)	O
,	O
and	O
yet	O
maintain	O
their	O
therapeutic	B:C1527144
effect	I:C1527144
with	O
increased	O
survival	O
.	O

Carbon	B:C0007018
monoxide	I:C0007018
preconditioned	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
able	O
to	O
alleviate	O
organ	O
injury	I:C0332675
,	O
improve	O
bacterial	O
clearance	O
,	O
and	O
promote	O
the	O
resolution	O
of	O
inflammation	O
.	O

Carbon	O
monoxide	I:C0007018
preconditioned	O
mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
able	O
to	O
alleviate	O
organ	O
injury	I:C0332675
,	O
improve	O
bacterial	O
clearance	O
,	O
and	O
promote	O
the	O
resolution	O
of	O
inflammation	O
.	O

Carbon	O
monoxide	I:C0007018
preconditioned	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
able	O
to	O
alleviate	O
organ	B:C0332675
injury	I:C0332675
,	O
improve	O
bacterial	O
clearance	O
,	O
and	O
promote	O
the	O
resolution	O
of	O
inflammation	O
.	O

Carbon	O
monoxide	I:C0007018
preconditioned	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
able	O
to	O
alleviate	O
organ	O
injury	I:C0332675
,	O
improve	B:C0184511
bacterial	O
clearance	O
,	O
and	O
promote	O
the	O
resolution	O
of	O
inflammation	O
.	O

Carbon	O
monoxide	I:C0007018
preconditioned	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
able	O
to	O
alleviate	O
organ	O
injury	I:C0332675
,	O
improve	O
bacterial	O
clearance	O
,	O
and	O
promote	O
the	O
resolution	B:C1514893
of	O
inflammation	O
.	O

Carbon	O
monoxide	I:C0007018
preconditioned	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
were	O
also	O
able	O
to	O
alleviate	O
organ	O
injury	I:C0332675
,	O
improve	O
bacterial	O
clearance	O
,	O
and	O
promote	O
the	O
resolution	O
of	O
inflammation	B:C0021368
.	O

Mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
with	O
docosahexaenoic	O
acid	I:C0556150
substrate	O
,	O
produced	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
particularly	O
D-	O
series	O
resolvins	O
,	O
which	O
promoted	O
survival	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
exposed	O
to	O
carbon	B:C0007018
monoxide	I:C0007018
,	O
with	O
docosahexaenoic	O
acid	I:C0556150
substrate	O
,	O
produced	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
particularly	O
D-	O
series	O
resolvins	O
,	O
which	O
promoted	O
survival	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
with	O
docosahexaenoic	B:C0556150
acid	I:C0556150
substrate	O
,	O
produced	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
particularly	O
D-	O
series	O
resolvins	O
,	O
which	O
promoted	O
survival	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
with	O
docosahexaenoic	O
acid	I:C0556150
substrate	O
,	O
produced	O
specialized	O
proresolving	B:C0243095
lipid	O
mediators	O
,	O
particularly	O
D-	O
series	O
resolvins	O
,	O
which	O
promoted	O
survival	O
.	O

Mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
with	O
docosahexaenoic	O
acid	I:C0556150
substrate	O
,	O
produced	O
specialized	O
proresolving	O
lipid	O
mediators	O
,	O
particularly	O
D-	O
series	O
resolvins	B:C4288292
,	O
which	O
promoted	O
survival	O
.	O

Silencing	B:C0598496
of	O
lipoxygenase	O
pathways	I:C1157322
(	O
5	O
-	I:C1151570
lipoxygenase	I:C1151570
and	O
12	O
/	O
15	O
-	I:C1324412
lipoxygenase	I:C1324412
)	O
,	O
which	O
are	O
important	O
enzymes	O
for	O
specialized	O
proresolving	O
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
bestowed	O
on	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
by	O
carbon	O
monoxide	I:C0007018
.	O

Silencing	O
of	O
lipoxygenase	B:C1157322
pathways	I:C1157322
(	O
5	O
-	I:C1151570
lipoxygenase	I:C1151570
and	O
12	O
/	O
15	O
-	I:C1324412
lipoxygenase	I:C1324412
)	O
,	O
which	O
are	O
important	O
enzymes	O
for	O
specialized	O
proresolving	O
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
bestowed	O
on	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
by	O
carbon	O
monoxide	I:C0007018
.	O

Silencing	O
of	O
lipoxygenase	O
pathways	I:C1157322
(	O
5	B:C1151570
-	I:C1151570
lipoxygenase	I:C1151570
and	O
12	O
/	O
15	O
-	I:C1324412
lipoxygenase	I:C1324412
)	O
,	O
which	O
are	O
important	O
enzymes	O
for	O
specialized	O
proresolving	O
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
bestowed	O
on	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
by	O
carbon	O
monoxide	I:C0007018
.	O

Silencing	O
of	O
lipoxygenase	O
pathways	I:C1157322
(	O
5	O
-	I:C1151570
lipoxygenase	I:C1151570
and	O
12	B:C1151569
/	O
15	O
-	I:C1324412
lipoxygenase	I:C1324412
)	O
,	O
which	O
are	O
important	O
enzymes	O
for	O
specialized	O
proresolving	O
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
bestowed	O
on	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
by	O
carbon	O
monoxide	I:C0007018
.	O

Silencing	O
of	O
lipoxygenase	O
pathways	I:C1157322
(	O
5	O
-	I:C1151570
lipoxygenase	I:C1151570
and	O
12	O
/	O
15	B:C1324412
-	I:C1324412
lipoxygenase	I:C1324412
)	O
,	O
which	O
are	O
important	O
enzymes	O
for	O
specialized	O
proresolving	O
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
bestowed	O
on	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
by	O
carbon	O
monoxide	I:C0007018
.	O

Silencing	O
of	O
lipoxygenase	O
pathways	I:C1157322
(	O
5	O
-	I:C1151570
lipoxygenase	I:C1151570
and	O
12	O
/	O
15	O
-	I:C1324412
lipoxygenase	I:C1324412
)	O
,	O
which	O
are	O
important	O
enzymes	B:C0014442
for	O
specialized	O
proresolving	O
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
bestowed	O
on	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
by	O
carbon	O
monoxide	I:C0007018
.	O

Silencing	O
of	O
lipoxygenase	O
pathways	I:C1157322
(	O
5	O
-	I:C1151570
lipoxygenase	I:C1151570
and	O
12	O
/	O
15	O
-	I:C1324412
lipoxygenase	I:C1324412
)	O
,	O
which	O
are	O
important	O
enzymes	O
for	O
specialized	O
proresolving	B:C0243095
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
bestowed	O
on	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
by	O
carbon	O
monoxide	I:C0007018
.	O

Silencing	O
of	O
lipoxygenase	O
pathways	I:C1157322
(	O
5	O
-	I:C1151570
lipoxygenase	I:C1151570
and	O
12	O
/	O
15	O
-	I:C1324412
lipoxygenase	I:C1324412
)	O
,	O
which	O
are	O
important	O
enzymes	O
for	O
specialized	O
proresolving	O
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
bestowed	O
on	O
mesenchymal	B:C3178844
stromal	I:C3178844
cells	I:C3178844
by	O
carbon	O
monoxide	I:C0007018
.	O

Silencing	O
of	O
lipoxygenase	O
pathways	I:C1157322
(	O
5	O
-	I:C1151570
lipoxygenase	I:C1151570
and	O
12	O
/	O
15	O
-	I:C1324412
lipoxygenase	I:C1324412
)	O
,	O
which	O
are	O
important	O
enzymes	O
for	O
specialized	O
proresolving	O
lipid	O
mediator	O
biosynthesis	O
,	O
resulted	O
in	O
a	O
loss	O
of	O
therapeutic	O
benefit	O
bestowed	O
on	O
mesenchymal	O
stromal	I:C3178844
cells	I:C3178844
by	O
carbon	B:C0007018
monoxide	I:C0007018
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
production	O
of	O
specialized	O
proresolving	B:C0243095
lipid	O
mediators	O
contribute	O
to	O
improved	O
mesenchymal	O
stromal	I:C3178844
cell	I:C3178844
efficacy	O
when	O
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
resulting	O
in	O
an	O
improved	O
therapeutic	O
response	I:C0521982
during	O
sepsis	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
contribute	O
to	O
improved	B:C0184511
mesenchymal	O
stromal	I:C3178844
cell	I:C3178844
efficacy	O
when	O
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
resulting	O
in	O
an	O
improved	O
therapeutic	O
response	I:C0521982
during	O
sepsis	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
contribute	O
to	O
improved	O
mesenchymal	B:C3178844
stromal	I:C3178844
cell	I:C3178844
efficacy	O
when	O
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
resulting	O
in	O
an	O
improved	O
therapeutic	O
response	I:C0521982
during	O
sepsis	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
contribute	O
to	O
improved	O
mesenchymal	O
stromal	I:C3178844
cell	I:C3178844
efficacy	O
when	O
exposed	O
to	O
carbon	B:C0007018
monoxide	I:C0007018
,	O
resulting	O
in	O
an	O
improved	O
therapeutic	O
response	I:C0521982
during	O
sepsis	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
contribute	O
to	O
improved	O
mesenchymal	O
stromal	I:C3178844
cell	I:C3178844
efficacy	O
when	O
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
resulting	O
in	O
an	O
improved	B:C0184511
therapeutic	O
response	I:C0521982
during	O
sepsis	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
contribute	O
to	O
improved	O
mesenchymal	O
stromal	I:C3178844
cell	I:C3178844
efficacy	O
when	O
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
resulting	O
in	O
an	O
improved	O
therapeutic	B:C0521982
response	I:C0521982
during	O
sepsis	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
production	O
of	O
specialized	O
proresolving	O
lipid	O
mediators	O
contribute	O
to	O
improved	O
mesenchymal	O
stromal	I:C3178844
cell	I:C3178844
efficacy	O
when	O
exposed	O
to	O
carbon	O
monoxide	I:C0007018
,	O
resulting	O
in	O
an	O
improved	O
therapeutic	O
response	I:C0521982
during	O
sepsis	B:C0243026
.	O

